期刊
NUCLEIC ACIDS RESEARCH
卷 51, 期 5, 页码 2108-2116出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac877
关键词
-
The tumor-suppressor proteins BRCA1 and BARD1 play important roles in transcriptional repression and DNA damage repair, and their functions are mediated through mono-ubiquitylation of histone H2A in nucleosomes. The study in C. elegans reveals that the orthologs BRC-1 and BRD-1 retain many functions of their human counterparts, including enzymatic activity toward nucleosomes. Despite differences in binding modes, BRC-1 and BRD-1 also contribute to gene repression in C. elegans. This highlights the conservation of these functions and allows further investigation using this model organism.
The tumor-suppressor proteins BRCA1 and BARD1 function as an E3 ubiquitin ligase to facilitate transcriptional repression and DNA damage repair. This is mediated in-part through its ability to mono-ubiquitylate histone H2A in nucleosomes. Studies in Caenorhabditis elegans have been used to elucidate numerous functions of BRCA1 and BARD1; however, it has not been established that the C. elegans orthologs, BRC-1 and BRD-1, retain all the functions of their human counterparts. Here we explore the conservation of enzymatic activity toward nucleosomes which leads to repression of estrogen-metabolizing cytochrome P450 (cyp) genes in humans. Biochemical assays establish that BRC-1 and BRD-1 contribute to ubiquitylation of histone H2A in the nucleosome. Mutational analysis shows that while BRC-1 likely binds the nucleosome using a conserved interface, BRD-1 and BARD1 have evolved different modes of binding, resulting in a difference in the placement of ubiquitin on H2A. Gene expression analysis reveals that in spite of this difference, BRC-1 and BRD-1 also contribute to cyp gene repression in C. elegans. Establishing conservation of these functions in C. elegans allows for use of this powerful model organism to address remaining questions regarding regulation of gene expression by BRCA1 and BARD1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据